I agree that this site is using cookies. You can find further informations here.
X
Meca-Lallana, José
253  results:
Search for persons X
?
1

Baseline Inflammatory Status Reveals Dichotomic Immune Mech..:

Fernández-Velasco, José I. ; Monreal, Enric ; Kuhle, Jens...
Frontiers in Immunology.  13 (2022)  - p. , 2022
Link: https://doi.org/10.3389/..
 
?
2

Impact of neuromyelitis optica spectrum disorder on quality..:

Meca-Lallana, José ; Gómez-Ballesteros, Rocío ; Pérez-Miralles, Francisco...
Journal of the Neurological Sciences.  429 (2021)  - p. 118844 , 2021
Link: https://doi.org/10.1016/..
 
?
3

Role of B Cell Profile for Predicting Secondary Autoimmunit..:

Walo-Delgado, Paulette Esperanza ; Monreal, Enric ; Medina, Silvia...
Frontiers in Immunology.  12 (2021)  - p. , 2021
Link: https://doi.org/10.3389/..
 
?
4

Spanish real-world experience with fingolimod in relapsing-..:

Barrero, Francisco ; Mallada-Frechin, Javier ; Martínez-Ginés, María Luisa...
PLOS ONE.  15 (2020)  4 - p. e0230846 , 2020
Link: https://doi.org/10.1371/..
 
?
5

Effectiveness of Fingolimod versus Natalizumab as Second-Li..:

Meca-Lallana, José ; Ayuso, Teresa ; Martínez-Yelamos, Sergio...
European Neurology.  83 (2020)  1 - p. 25-33 , 2020
Link: https://doi.org/10.1159/..
 
?
6

The patients' perspective in multiple sclerosis: the Sympto..:

Meca-Lallana, José ; Hernández-Pérez, Miguel A. ; Sempere, Angel P....
Neurology.  94 (2020)  15_supplement - p. , 2020
Link: https://doi.org/10.1212/..
 
?
7

Psychometric Properties of the SymptoMScreen Questionnaire ..:

Meca-Lallana, José ; Maurino, Jorge ; Hernández-Pérez, Miguel Ángel...
Neurology and Therapy.  9 (2020)  1 - p. 173-179 , 2020
Link: https://doi.org/10.1007/..
 
?
8

Long-Term Effect of Teriflunomide in Subgroups Defined by P..:

Comi, Giancarlo ; Freedman, Mark ; Meca-Lallana, José...
Neurology.  92 (2019)  15_supplement - p. , 2019
Link: https://doi.org/10.1212/..
 
?
9

Effectiveness and safety of fingolimod in Spanish Relapsing..:

Martínez, Marisa ; Barrero, Francisco ; Marzo, Eugenia...
Neurology.  90 (2018)  15_supplement - p. , 2018
Link: https://doi.org/10.1212/..
 
?
10

Treatment Satisfaction With Teriflunomide in Patients Switc..:

Vermersch, Patrick ; Gold, Ralf ; Meca-Lallana, José...
Neurology.  90 (2018)  15_supplement - p. , 2018
Link: https://doi.org/10.1212/..
 
?
11

Tolerability and safety of Fingolimod in Spanish Clinical p..:

Izquierdo, Guillermo ; Meca-Lallana, Jose ; Ara, Jose Ramon...
Neurology.  88 (2017)  16_supplement - p. , 2017
Link: https://doi.org/10.1212/..
 
?
12

Effectiveness of fingolimod in patients with relapsing-remi..:

Meca-Lallana, Jose ; Izquierdo, Guillermo ; Ara, Jose Ramon...
Neurology.  88 (2017)  16_supplement - p. , 2017
Link: https://doi.org/10.1212/..
 
?
13

Anti-JC virus seroprevalence in a Spanish multiple sclerosi..:

Aladro, Yolanda ; Terrero, Rodrigo ; Cerezo, Marta...
Journal of the Neurological Sciences.  365 (2016)  - p. 16-21 , 2016
Link: https://doi.org/10.1016/..
 
?
14

Safety of Rituximab as First-line Therapy in Neuromyelitis ..:

Carreón-Guarnizo, Ester ; Hernández-Clares, Rocio ; Palazón-Cabanes, Begoña...
Neurology.  84 (2015)  14_supplement - p. , 2015
Link: https://doi.org/10.1212/..
 
?
15

Cost analysis of glatiramer acetate versus interferon-β for..:

Sánchez-de la Rosa, Rainel ; García-Bujalance, Laura ; Meca-Lallana, José
Health Economics Review.  5 (2015)  1 - p. , 2015
Link: https://doi.org/10.1186/..
 
1-15